Abstract
CREBH mediates inflammatory signaling to VLDL overproduction in metabolic stress. Activation of CREBH in inflammation enhances mRNA and protein expression of apoB. CREBH presents a potential novel therapeutic target for hyperlipoproteinemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have